| 14.33 |  +0.54 / +3.92% |
Data as of 3:59pm ET | Day’s Change |
| 14.33 |  0.00 / 0.00% |
Volume: 196.00 |
| Previous close | 13.79 |
| Today’s open | 13.96 |
| Day’s range | 13.58 - 14.50 |
| Volume | 35,400 |
| Average volume (3 months) | 190,583 |
| Market cap | $267.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -2,787.88% |
| Earnings growth (this year) | +101.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -73.83% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| POZNPOZEN Inc | +0.26 | +3.07% |
| TTPHTetraphase Pharmaceu... | +1.25 | +14.67% |
| PGNXProgenics Pharmaceut... | +0.16 | +4.71% |
| CCXIChemoCentryx Inc | +0.05 | +0.95% |
| Next reporting date | May 28, 2014 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$10.6M |
| Net profit margin | -265.59% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
Chief Financial Officer & Head-Media Relations Brian M. Hahn |
Corporate headquarters Gaithersburg, Maryland |
.
